第5课强大获益，ACS患者他汀治疗决策思考课件.ppt

* * 2012 FDA解除他汀常规检测肝功能的限制指出他汀肝脏安全无需顾虑 * * 综合以上ACS患者他汀治疗早、严、长的原则，以及中国患者的实际情况，霍勇等著名专家提出ACS患者他汀续贯治疗新方案，对于急诊或择期PCI的患者建议 Patients with ACS have heightened focal inflammation within the vessel wall as well as evidence of a systemic inflammatory response (summarized in Table 3). In particular, T-lymphocytes present in the plaque produce a number of inflammatory proteins (cytokines), including interferon (IFN)-gamma, which lead to a decrease in collagen production by vascular smooth muscle cells. Activated macrophages produce large quantities of matrix metalloproteinases and elastases, whic